Pretreatment microRNA levels can predict HBsAg clearance in CHB patients treated with pegylated interferon α-2a

BACKGROUND: To investigate the predictive capability of microRNAs (miRNAs) prior treatment for HBsAg clearance in chronic hepatitis B (CHB) treated with pegylated interferon α-2a (PEG-IFNα-2a). METHODS: The treatment effect was determined by HBsAg clearance and subjects were classified into HBsAg cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanlin, Liu, Ming, Deng, Ying, Guo, Yan, Zhang, Xuqing, Xiang, Dedong, Jiang, Li, You, Zhonglan, Wu, Yi, Li, Maoshi, Mao, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914056/
https://www.ncbi.nlm.nih.gov/pubmed/29685146
http://dx.doi.org/10.1186/s12985-018-0982-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914056/
https://www.ncbi.nlm.nih.gov/pubmed/29685146
http://dx.doi.org/10.1186/s12985-018-0982-y

Ejemplares similares